Evaluation of E-cigarette aerosol in in vivo nonclinical models
Ended Awarded Last action
- Contract number
- HHSF22301004T
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $2,472,244
Award facts
- Opportunity
-
- 14223SOL00077 Solicitation number
- In Vivo Toxicology of Tobacco and Related Products Award Notice · Posted Aug 5, 2014
- Contract value 100% obligated
- $2,472,244.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Albuquerque, NM 87108, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $173,000 | |
| Original award | $2,299,244 |
About this award
This firm fixed-price delivery order was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to the Lovelace Biomedical Research Institute, a not-for-profit contract research organization. The $2,472,244.00 contract is for the evaluation of e-cigarette aerosol in in vivo nonclinical models and was issued under the In Vivo Toxicology of Tobacco 2015-2020 indefinite delivery, indefinite quantity (IDIQ) contract. Lovelace Biomedical Research Institute has previously served as a prime contractor conducting preclinical research and testing services for medical countermeasure development programs at HHS agencies. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract HHSF22301004T?
HHSF22301004T was awarded to Lovelace Biomedical Research Institute by Food and Drug Administration (Department of Health and Human Services) on August 14, 2017.
How much is contract HHSF22301004T worth?
The government has obligated $2,472,244 on HHSF22301004T.
Is contract HHSF22301004T an order under another contract?
Yes. HHSF22301004T is a delivery order under HHSF223201510032I, an indefinite delivery contract, on In Vivo Toxicology of Tobacco 2015-2020.
Was contract HHSF22301004T competed?
The extent of competition for HHSF22301004T was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award